An NS5A single optimized method to determine genotype, subtype and resistance profiles of Hepatitis C strains.

about

An NS5A single optimized method to determine genotype, subtype and resistance profiles of Hepatitis C strains.

Item

http://www.wikidata.org/entity/Q40114959

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

An NS5A single optimized metho ...... ofiles of Hepatitis C strains.

@en

type

Item

label

An NS5A single optimized metho ...... ofiles of Hepatitis C strains.

@en

prefLabel

An NS5A single optimized metho ...... ofiles of Hepatitis C strains.

@en

P1476

An NS5A single optimized metho ...... ofiles of Hepatitis C strains.

@en

P2093

Audrey Rodallec

http://www.w3.org/2001/XMLSchema#string

Bernard Besse

http://www.w3.org/2001/XMLSchema#string

Berthe-Marie Imbert-Marcille

http://www.w3.org/2001/XMLSchema#string

Caroline Luco

http://www.w3.org/2001/XMLSchema#string

Elisabeth Andre-Garnier

http://www.w3.org/2001/XMLSchema#string

Eric Billaud

http://www.w3.org/2001/XMLSchema#string

François Raffi

http://www.w3.org/2001/XMLSchema#string

Jérôme Gournay

http://www.w3.org/2001/XMLSchema#string

Laura Le Guen

http://www.w3.org/2001/XMLSchema#string

Marianne Coste-Burel

http://www.w3.org/2001/XMLSchema#string

P2860

Virologic Tools for HCV Drug Resistance Testing

Comparison of Hepatitis C Virus Genotyping by 5' Noncoding Region- and Core-Based Reverse Transcriptase PCR Assay with Sequencing and Use of the Assay for Determining Subtype Distribution in India

MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods

HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors

Geno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents

Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource

New antiviral therapies for chronic hepatitis C

All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study.

Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin.

Emerging therapeutic options in hepatitis C virus infection.

P304

e0179562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0179562

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Berthe-Marie Imbert-Marcille

P577

2017-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28727784

http://www.w3.org/2001/XMLSchema#string

P932

5519038

http://www.w3.org/2001/XMLSchema#string